Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring Balloon Pre-dilatation (RIBS VI Scoring)

PHASE4UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2021

Conditions
Coronary In-stent Restenosis
Interventions
DEVICE

Bioresorbable vascular scaffold. Absorb GT1 (Abbott)

Trial Locations (10)

15006

RECRUITING

Complexo Universitario Hospitalario de Santiago, Santiago de Compostela

18014

RECRUITING

Hospital Universitario Virgen de las Nieves, Granada

28006

RECRUITING

Hospital Universitario de La Princesa, Madrid

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

28222

RECRUITING

Hospital Universitario Puerta de Hierro, Majadahonda

33006

RECRUITING

Hospital Central de Asturias, Oviedo

38320

RECRUITING

Hospital Universitario de Canarias, San Cristóbal de La Laguna

08025

RECRUITING

Hospital de la Santa Creu i Sant Pau, Barcelona

08036

RECRUITING

Hospital Clinic de Barcelona, Barcelona

08907

RECRUITING

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

OTHER

collaborator

Instituto de Investigación Sanitaria Hospital Universitario de la Princesa

OTHER

collaborator

Abbott Medical Devices

INDUSTRY

collaborator

Terumo Medical Corporation

INDUSTRY

lead

Spanish Society of Cardiology

OTHER

NCT03069066 - Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring Balloon Pre-dilatation (RIBS VI Scoring) | Biotech Hunter | Biotech Hunter